An old drug and different ways to treat cutaneous leishmaniasis: Intralesional and intramuscular meglumine antimoniate in a reference center, Rio de Janeiro, Brazil

BACKGROUND: Treatment of cutaneous leishmaniasis (CL) remains challenging since the drugs currently used are quite toxic, thus contributing to lethality unrelated to the disease itself but to adverse events (AE). The main objective was to evaluate different treatment regimens with meglumine antimoni...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveira-Ribeiro, Carla, Pimentel, Maria Inês Fernandes, Oliveira, Liliane de Fátima Antonio, Vasconcellos, Érica de Camargo Ferreira e, Conceição-Silva, Fatima, Schubach, Armando de Oliveira, Fagundes, Aline, de Mello, Cintia Xavier, Mouta-Confort, Eliame, Miranda, Luciana de Freitas Campos, Valete-Rosalino, Claudia Maria, Martins, Ana Cristina da Costa, de Oliveira, Raquel de Vasconcellos Carvalhaes, Quintella, Leonardo Pereira, Lyra, Marcelo Rosandiski
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491910/
https://www.ncbi.nlm.nih.gov/pubmed/34555016
http://dx.doi.org/10.1371/journal.pntd.0009734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491910/
https://www.ncbi.nlm.nih.gov/pubmed/34555016
http://dx.doi.org/10.1371/journal.pntd.0009734

Ejemplares similares